The conventional approaches to diagnosing cancer are expensive, often involve exposure to radiation, and struggle to identify early-stage lung cancer. As a result, the five-year survival rate is significantly reduced. Fortunately, promising alternatives using magnetoresistance (MR) and magneto-plasmonic sensors have emerged for swiftly, accurately, and inexpensively detecting cancer in its initial phases. These sensor technologies offer numerous advantages over their counterparts, such as minimal background noise, immunity to environmental influences, compatibility with nanofabrication methods, ability to detect multiple substances simultaneously, straightforward integration, high specificity, distinctive identifying capabilities, real-time monitoring, stability, label-free detection, and remarkable sensitivity for detecting individual molecules. Nevertheless, since the use of these techniques for cancer biomarker detection is relatively new, it is essential to conduct a bibliometric analysis and review recent literature to offer guidance to both early-career and established researchers in this domain. Consequently, this study performs a scientometric evaluation of the literature related to cancer biomarker detection using MR and magneto-plasmonic methods. The objective is to pinpoint current preferred techniques and challenges by examining statistics such as publication numbers, authors, countries, journals, and research interests. Furthermore, the paper also presents the latest advancements in MR and magneto-plasmonic sensors for cancer biomarker detection, with a focus on the last decade. In addition, an overview of the ongoing research in the field of MR and magneto-plasmonic sensors for detecting cancer biomarkers is highlighted. Finally, a summary on the level of current research including the significant accomplishments, challenges, and outlooks of MR and magneto-plasmonic sensors for the detection of cancer biomarkers are highlighted.

诊断癌症的传统方法价格昂贵，通常涉及辐射，并且难以识别早期肺癌。结果，五年生存率显着降低。幸运的是，使用磁阻 (MR) 和磁等离子体传感器的有前途的替代方案已经出现，可以在癌症的初始阶段快速、准确且廉价地检测癌症。这些传感器技术比同类技术具有许多优势，例如背景噪声最小、不受环境影响、与纳米加工方法兼容、同时检测多种物质的能力、直接集成、高特异性、独特的识别能力、实时监控、稳定性、无标记检测，以及检测单个分子的卓越灵敏度。然而，由于使用这些技术进行癌症生物标志物检测相对较新，因此有必要进行文献计量分析并回顾最新文献，以便为该领域的早期职业和成熟研究人员提供指导。因此，本研究使用 MR 和磁等离子体方法对与癌症生物标志物检测相关的文献进行了科学计量学评估。目的是通过检查出版物数量、作者、国家、期刊和研究兴趣等统计数据来确定当前首选的技术和挑战。此外，本文还介绍了用于癌症生物标志物检测的 MR 和磁等离子体传感器的最新进展，重点关注过去十年。此外，重点介绍了用于检测癌症生物标志物的 MR 和磁等离子体传感器领域正在进行的研究概述。最后，对当前研究水平进行了总结，包括用于检测癌症生物标志物的 MR 和磁等离子体传感器的重大成就、挑战和前景。